Government panel seeks additional data from SII on Covovax

In August 2020, U.S.-based vaccine maker Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries

Click here for more...
from #Bangladesh #News aka Bangladesh News Now!!!